Oncology - Exercise may become part of standard treatment for metastatic breast cancer, study suggests
Can't see this email? View it online
   
  Oncology  
  The latest oncology news from News Medical  
 

10 key factors to improve your cell counting results10 key factors to improve your cell counting results

Cell counting plays a crucial role in the development and manufacturing of cell and gene therapies as well as regenerative medicine. Modernization of cell counting methods is vital to support the use of these advanced biological products.

This eBook describes considerations and best practices for improving the quality of your cell counting results, based on articles from the ISO Cell Counting Standards.

Download eBook
 
   Exercise may become part of standard treatment for metastatic breast cancer, study suggestsExercise may become part of standard treatment for metastatic breast cancer, study suggests
 
Among patients with metastatic breast cancer, those who took part in a nine-month structured exercise program reported less fatigue and an improved quality of life compared to those who did not undergo the exercise program, according to results from the PREFERABLE-EFFECT trial presented at the San Antonio Breast Cancer Symposium.
 
   UCLA researchers win NCI grants to advance liquid biopsy for early detection of cancerUCLA researchers win NCI grants to advance liquid biopsy for early detection of cancer
 
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have received two grants totaling $9.1 million from the National Cancer Institute to advance liquid biopsy technologies for the early detection of cancer, which can significantly improve treatment outcomes and reduce the number of deaths caused by the disease.
 
 

Something About Science Podcast

 
 Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancer
 
Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancerFor patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase the risk of disease recurrence or death five years after surgery, according to results from the NRG Oncology/NSABP B-51/RTOG 1304 clinical trial presented at the San Antonio Breast Cancer Symposium.
 
 
 Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression
 
Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progressionStudy demonstrates that inhibiting stromal class I histone deacetylases (HDACs) can effectively slow down pancreatic cancer progression, shedding light on a new therapeutic approach targeting the tumor microenvironment.
 
 
 A class of diabetes medications may reduce the risk of colorectal cancer
 
A class of diabetes medications may reduce the risk of colorectal cancerA groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
 
 
 Revolutionary self-folding nanoscale MRI agent sharpens cancer imaging
 
Revolutionary self-folding nanoscale MRI agent sharpens cancer imagingMedical imaging often facilitates the successful diagnosis and management of cancerous growths. In particular, magnetic resonance imaging (MRI) is extensively used, especially with contrast agents, because of its high resolution.
 
 
 Breakthrough discovery paves the way for new methods to detect and treat leukemia
 
Breakthrough discovery paves the way for new methods to detect and treat leukemiaResearchers led by François Fuks - Laboratory of Cancer Epigenetics, ULB Faculty of Medicine, ULB Cancer Research Center and Jules Bordet Institute, H.U.B. - have made a major breakthrough in the understanding and treatment of leukemia.
 
 
 Fused pancreatic cancer organoid system captures tumor heterogeneity and drug resistance
 
Fused pancreatic cancer organoid system captures tumor heterogeneity and drug resistancePancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial cells, is the most common form of pancreatic cancer, with a very high mortality rate. This elevated mortality is associated with the unique tumor microenvironment (TME), known for increased resistance to chemotherapy and high metastatic potential.
 
 

How would you rate today's newsletter?